In a new study, researchers from the University of Chicago discovered that zeaxanthin, a plant-derived carotenoid best known ...

Webcasts of the fireside chat and presentation will be available on the “ Events and Presentations ” section of the Company’s website at ir.tscan.com. Archived replays of the webcasts will be ...

About Medigene AG Medigene AG (FSE: MDG1) is an immuno-oncology platform company dedicated to developing T cell receptor (TCR)-guided therapies to effectively eliminate cancer.

This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between ...

A carotenoid that's already widely available in fruit and vegetables, and as a supplement, has been found to bolster the ...

Replay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 ...

New research, published in ImmunoHorizons, paves the way for more personalized veterinary care for dogs that could help dog ...